ILTOO PHARMA
ILTOO Pharma is a clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). Based on a deep expertise in translational research and clinical immunology, ILTOO Pharma is pioneering the field of regulatory T cells (Tregs)-mediated immunotherapies.
ILTOO PHARMA
Social Links:
Industry:
Biotechnology Health Care
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.iltoopharma.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Content Delivery Network Font Awesome Apache Wordpress Plugins Sitelinks Search Box
Official Site Inspections
http://www.iltoopharma.com Semrush global rank: 5.45 M Semrush visits lastest month: 1.56 K
- Host name: cluster023.hosting.ovh.net
- IP address: 164.132.235.17
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Iltoo Pharma"
Iltoo Pharma - Crunchbase Company Profile & Funding
ILTOO Pharma is a clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). Based on a deep expertise in translational …See details»
ILTOO Pharma - VentureRadar
" ILTOO Pharma is a clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). Based on a deep expertise in translational …See details»
ILTOO Pharma Company Profile 2024: Valuation, Funding
ILTOO Pharma was founded in 2011. Where is ILTOO Pharma headquartered? ILTOO Pharma is headquartered in Paris, France. What is the size of ILTOO Pharma? ILTOO Pharma has 5 total employees. What industry is ILTOO Pharma in? ILTOO Pharma’s primary industry is …See details»
ILTOO Pharma - Transimmunom
The drug based on this discovery and developed by ILTOO Pharma is named ILT-101.When used at doses 10 to 100 times lower than the ones used in cancer (Proleukin®, Novartis, Chiron), rhIL2 does not stimulate immunity but rather restores self-tolerance by specifically activates cells …See details»
ILTOO Pharma SAS - Drug pipelines, Patents, Clinical trials - Synapse
Explore ILTOO Pharma SAS with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 8 news, and 5 literature, Disease Domain:Nervous System Diseases, Immune System Diseases, Endocrinology and Metabolic Disease, Technology Platform:Interleukins, …See details»
Iltoo Pharma - Overview, News & Similar companies - ZoomInfo
ILTOO Pharma is a clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). Based on a deep expertise in translational …See details»
ILTOO PHARMA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ILTOO PHARMA of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet. ILTOO PHARMA. D&B Business Directory HOME / BUSINESS DIRECTORY / …See details»
Iltoo Pharma - Company Profile - Tracxn
Nov 5, 2024 Iltoo Pharma, a clinical-stage biotech, is developing treatments for autoimmune and inflammatory disorders (ADs). Its lead product, ILT-101, is an IL-2-based therapy and being developed to treat Systemic lupus erythematosus (SLE) (Phase 2) and type-1 diabetes (T1D) …See details»
ILTOO Pharma - Products, Competitors, Financials, Employees ...
ILTOO Pharma specializes in the development of therapies for auto-/neuro-immune and inflammatory diseases within the pharmaceutical industry. The company is pioneering Tregs directed therapies to treat a broad range of autoimmune and neuro-immune conditions. ILTOO …See details»
ILTOO Pharma - Craft
ILTOO Pharma is a biotechnology company dedicated to the development of biotherapies for the treatment of autoimmune and inflammatory disorders (ADs). It is engaged in the field of regulatory T cells (Tregs)-mediated immunotherapies. ILTOO's product ILT-101 is IL-2-based therapy.See details»
Iltoo Pharma - Contacts, Employees, Board Members ... - Crunchbase
ILTOO Pharma is a clinical-stage biotechnology company. Start Free Trial . Chrome ExtensionSee details»
ILTOO Pharma | Biotechnology - The Pharmaletter
ILTOO Pharma. A French clinical-stage biotechnology company dedicated to the development of biotherapies that have the ability to balance the immune system and revolutionize the treatment of autoimmune and inflammatory disorders (ADs). ILTOO Pharma is developing regulatory T cell …See details»
ILTOO Pharma and the MIROCALS Consortium announce the …
May 9, 2023 ILTOO Pharma SAS of Paris France and the European MIROCALS ConsorCum announced today the signing of a Worldwide Exclusive License Agreement granng ILTOO Pharma the use of data from the H2020 funded MIROCALS project to develop low dose …See details»
ILTOO Pharma will be joining the only dedicated end-to-end Treg ...
ILTOO Pharma entered into an option license agreement in May 2017 with Servier for ex-US/Japan rights with regard to ILT-101. The company has already initiated two multicentric, randomized, placebo-controlled, double-blind phase 2 clinical trials evaluating the efficacy and …See details»
ILTOO Pharma and the MIROCALS Consortium announce the
May 12, 2023 Professor David Klatzmann, founder of ILTOO Pharma and Chairman of ILTOO Scientific Advisory Board, who pioneered the field of low dose IL-2 (IL-2LD) treatments for autoimmune diseases and conducted clinical trials in Systemic Lupus Erythematosus, Multiple …See details»
ILTOO Pharma announces the presentation of Phase IIb trial …
Nov 21, 2022 ILTOO Pharma is dedicated to the development of immunotherapies with Low Dose IL-2 for the treatment of auto/neuroimmune and inflammatory disorders. The company is based in central Paris near to a thriving community of Bio Pharma research and …See details»
What is Iltoo Pharma? Company Culture, Mission, Values
Iltoo Pharma. Is this your company? This employer has not claimed their Employer Profile and is missing out on connecting with our community. Connect with our community. Claim your Free Employer Profile to start telling your employer brand story to reach top talent. Iltoo Pharma. …See details»
ILTOO Pharma Announces Managed Access Program for ALS …
About ILTOO Pharma: ILTOO Pharma SAS is dedicated to the development of immunotherapies with IL-2LD for the treatment of auto-immune, neuro-immune and inflammatory disorders. The company has been focused for more than a decade on pioneering the use of Interleukin 2 at …See details»
PRESS RELEASE - iltoopharma.com
May 23, 2023 PRESS RELEASE ILTOO Pharma announces that ILT-101 has achieved Orphan Drug Designation Paris, 23 May 2023 ILTOO Pharma SAS today announced that the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) have granted …See details»
PRESS RELEASE - iltoopharma.com
Dec 6, 2022 ILTOO Pharma is dedicated to the development of immunotherapies with IL-2 LD for the treatment of auto/neuroimmune and inflammatory disorders. The company is based in central Paris near to a thriving community of Bio Pharma research and commercialisation. For …See details»